CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
8% Dexamethasone Sodium Phosphate - Visulex +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02309385
NCT02309385Phase 2Completed
CompareCT.gov

A Randomized, Parallel Group, Double-masked, Active-controlled Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of Dexamethasone Sodium Phosphate Visulex System for the Treatment of Non-infectious Anterior Uveitis

Aciont Inc·interventional·Posted Dec 5, 2014·Updated Apr 27, 2017

In Brief

A Phase 2 clinical trial evaluating 8% Dexamethasone Sodium Phosphate - Visulex, 15% Dexamethasone Sodium Phosphate - Visulex, and 1 other intervention for Non-Infectious Anterior Uveitis. Completed, enrolled 44 participants across 6 sites.

Detailed Summary

The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-Infectious Anterior Uveitis
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 5, 2014
Enrollment StartOct 1, 2014
Primary CompletionMar 3, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 11.6 years ago

Interventions

8% Dexamethasone Sodium Phosphate - Visulexdrug

15% Dexamethasone Sodium Phosphate - Visulexdrug

Prednisolone Acetate (1%) Eye Dropsdrug